Front. Cell Dev. Biol.
Frontiers in Cell and Developmental Biology
Front. Cell Dev. Biol.
2296-634X
Frontiers Media S.A.
875280
10.3389/fcell.2022.875280
Cell and Developmental Biology
Correction
Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
Zhou et al.
Corrigendum: Targeting miRNAs in Diabetic Nephropathy
Zhou
Hong
1
Ni
Wei-Jian
2
3
*
Meng
Xiao-Ming
2
*
Tang
Li-Qin
3
*
1
Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
2
Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China
3
Department of Pharmacy, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Wei-Jian Ni, niweijian@ustc.edu.cn; Xiao-Ming Meng, mengxiaoming@ahmu.edu.cn; Li-Qin Tang, tangliqin@ustc.edu.cn
This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Cell and Developmental Biology
01
03
2022
2022
10
875280
14
02
2022
15
02
2022
Copyright © 2022 Zhou, Ni, Meng and Tang.
2022
Zhou, Ni, Meng and Tang
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy by Zhou, H., Ni, W.-J., Meng, X.-M., and Tang, L.-Q. (2021). Front. Cell Dev. Biol. 8:618536. doi:10.3389/fcell.2020.618536
epigenetic regulation
miRNAs
inflammatory
cellular signal transduction
therapeutic target
diabetic nephropathy
immune
In the published article, there was an error in affiliation 1. Instead of “Division of Life Sciences and Medicine, Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China”, it should be “Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China”.
In the published article, there was an error in affiliation 3. Instead of “Division of Life Sciences and Medicine, Department of Pharmacy, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China”, it should be “Department of Pharmacy, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.